Cargando…

CD19 LYMPHOCYTE PROLIFERATION INDUCED BY Bifidobacterium animalis subsp. lactis IN C57BL/6 MICE EXPERIMENTALLY INFECTED WITH Toxoplasma gondii

Toxoplasmosis is frequently acquired through the oral route by the ingestion of cysts or oocysts of Toxoplasma gondii. Once ingested, the parasites penetrate the intestinal epithelial cells and rapidly disseminate to all organs in the host. During T. gondii infection, the intestinal microbiota plays...

Descripción completa

Detalles Bibliográficos
Autores principales: RIBEIRO, Claudia de Mello, ZORGI, Nahiara Esteves, MEIRELES, Luciana Regina, GARCIA, João Luis, de ANDRADE, Heitor Franco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Instituto de Medicina Tropical 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826079/
https://www.ncbi.nlm.nih.gov/pubmed/27074320
http://dx.doi.org/10.1590/S1678-9946201658026
_version_ 1782426285384925184
author RIBEIRO, Claudia de Mello
ZORGI, Nahiara Esteves
MEIRELES, Luciana Regina
GARCIA, João Luis
de ANDRADE, Heitor Franco
author_facet RIBEIRO, Claudia de Mello
ZORGI, Nahiara Esteves
MEIRELES, Luciana Regina
GARCIA, João Luis
de ANDRADE, Heitor Franco
author_sort RIBEIRO, Claudia de Mello
collection PubMed
description Toxoplasmosis is frequently acquired through the oral route by the ingestion of cysts or oocysts of Toxoplasma gondii. Once ingested, the parasites penetrate the intestinal epithelial cells and rapidly disseminate to all organs in the host. During T. gondii infection, the intestinal microbiota plays an important role in stimulating a protective immune response against the parasite. In this sense the use of probiotics is worthy of note since they are live microorganisms that have beneficial effects on the host through stimulation of the immune response that can be important in the control of T. gondii proliferation and dissemination in the host. In the present study, the action of the probiotic Bifidobacterium animalis subsp. lactis was investigated in C57BL/6 mice infected with oocysts of ME49 strain of T. gondii. The probiotic had an immunomodulatory action, inducing CD19 lymphocyte proliferation and consequently increasing anti-T. gondii antibody level.Bifidobacterium animalis subsp. lactisprovided protection in supplemented mice, compared to the control group. In addition, supplemented animals had milder inflammatory process in the small intestine, indicating that the probiotic protects the intestinal mucosa during infection with T. gondii. It was concluded that the probioticB. animalis subsp. lactis induces humoral immune response capable of providing protection against T. gondii infection.
format Online
Article
Text
id pubmed-4826079
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Instituto de Medicina Tropical
record_format MEDLINE/PubMed
spelling pubmed-48260792016-04-21 CD19 LYMPHOCYTE PROLIFERATION INDUCED BY Bifidobacterium animalis subsp. lactis IN C57BL/6 MICE EXPERIMENTALLY INFECTED WITH Toxoplasma gondii RIBEIRO, Claudia de Mello ZORGI, Nahiara Esteves MEIRELES, Luciana Regina GARCIA, João Luis de ANDRADE, Heitor Franco Rev Inst Med Trop Sao Paulo Original Article Toxoplasmosis is frequently acquired through the oral route by the ingestion of cysts or oocysts of Toxoplasma gondii. Once ingested, the parasites penetrate the intestinal epithelial cells and rapidly disseminate to all organs in the host. During T. gondii infection, the intestinal microbiota plays an important role in stimulating a protective immune response against the parasite. In this sense the use of probiotics is worthy of note since they are live microorganisms that have beneficial effects on the host through stimulation of the immune response that can be important in the control of T. gondii proliferation and dissemination in the host. In the present study, the action of the probiotic Bifidobacterium animalis subsp. lactis was investigated in C57BL/6 mice infected with oocysts of ME49 strain of T. gondii. The probiotic had an immunomodulatory action, inducing CD19 lymphocyte proliferation and consequently increasing anti-T. gondii antibody level.Bifidobacterium animalis subsp. lactisprovided protection in supplemented mice, compared to the control group. In addition, supplemented animals had milder inflammatory process in the small intestine, indicating that the probiotic protects the intestinal mucosa during infection with T. gondii. It was concluded that the probioticB. animalis subsp. lactis induces humoral immune response capable of providing protection against T. gondii infection. Instituto de Medicina Tropical 2016-04-08 /pmc/articles/PMC4826079/ /pubmed/27074320 http://dx.doi.org/10.1590/S1678-9946201658026 Text en http://creativecommons.org/licenses/by-nc/4.0 This is an open-access article distributed under the terms of the Creative Commons Attribution License
spellingShingle Original Article
RIBEIRO, Claudia de Mello
ZORGI, Nahiara Esteves
MEIRELES, Luciana Regina
GARCIA, João Luis
de ANDRADE, Heitor Franco
CD19 LYMPHOCYTE PROLIFERATION INDUCED BY Bifidobacterium animalis subsp. lactis IN C57BL/6 MICE EXPERIMENTALLY INFECTED WITH Toxoplasma gondii
title CD19 LYMPHOCYTE PROLIFERATION INDUCED BY Bifidobacterium animalis subsp. lactis IN C57BL/6 MICE EXPERIMENTALLY INFECTED WITH Toxoplasma gondii
title_full CD19 LYMPHOCYTE PROLIFERATION INDUCED BY Bifidobacterium animalis subsp. lactis IN C57BL/6 MICE EXPERIMENTALLY INFECTED WITH Toxoplasma gondii
title_fullStr CD19 LYMPHOCYTE PROLIFERATION INDUCED BY Bifidobacterium animalis subsp. lactis IN C57BL/6 MICE EXPERIMENTALLY INFECTED WITH Toxoplasma gondii
title_full_unstemmed CD19 LYMPHOCYTE PROLIFERATION INDUCED BY Bifidobacterium animalis subsp. lactis IN C57BL/6 MICE EXPERIMENTALLY INFECTED WITH Toxoplasma gondii
title_short CD19 LYMPHOCYTE PROLIFERATION INDUCED BY Bifidobacterium animalis subsp. lactis IN C57BL/6 MICE EXPERIMENTALLY INFECTED WITH Toxoplasma gondii
title_sort cd19 lymphocyte proliferation induced by bifidobacterium animalis subsp. lactis in c57bl/6 mice experimentally infected with toxoplasma gondii
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826079/
https://www.ncbi.nlm.nih.gov/pubmed/27074320
http://dx.doi.org/10.1590/S1678-9946201658026
work_keys_str_mv AT ribeiroclaudiademello cd19lymphocyteproliferationinducedbybifidobacteriumanimalissubsplactisinc57bl6miceexperimentallyinfectedwithtoxoplasmagondii
AT zorginahiaraesteves cd19lymphocyteproliferationinducedbybifidobacteriumanimalissubsplactisinc57bl6miceexperimentallyinfectedwithtoxoplasmagondii
AT meireleslucianaregina cd19lymphocyteproliferationinducedbybifidobacteriumanimalissubsplactisinc57bl6miceexperimentallyinfectedwithtoxoplasmagondii
AT garciajoaoluis cd19lymphocyteproliferationinducedbybifidobacteriumanimalissubsplactisinc57bl6miceexperimentallyinfectedwithtoxoplasmagondii
AT deandradeheitorfranco cd19lymphocyteproliferationinducedbybifidobacteriumanimalissubsplactisinc57bl6miceexperimentallyinfectedwithtoxoplasmagondii